In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Drug Metabolism And Disposition

• Publication date

  2001-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 11181487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catalytic Activity of Cytochrome P-450 Isozyme 3 a Isolated from Liver Microsomes of Ethanol-treated Rabbits

  2001influential reference
• CYP2A6: a human coumarin 7-hydroxylase.

  2000cited by this paper
• Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6).

  2000cited by this paper
• Inhibition and induction of human cytochrome P450 (CYP) enzymes.

  1998cited by this paper
• (R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6.

  1998influential reference
• ( R )-( 1 )-MENTHOFURAN IS A POTENT , MECHANISM-BASED INACTIVATOR OF HUMAN LIVER CYTOCHROME P 450 2 A 6

  1998influential reference
• Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.

  1997cited by this paper
• In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.

  1997cited by this paper
• Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.

  1997influential reference
• The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism.

  1996cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• Competitive inhibition of coumarin 7‐hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP2A6

  1995cited by this paper
• The inhibition of CYP enzymes in mouse and human liver by pilocarpine

  1995cited by this paper
• Kinetic applications using high substrate and competitive inhibitor concentrations to determine Ki or Km.

  1994influential reference
• Use of in vitro human metabolism studies in drug development. An industrial perspective.

  1994cited by this paper
• Metabolic interactions of methoxsalen and coumarin in humans and mice.

  1994cited by this paper
• Isolation and characterization of human liver cytochrome P450 2C19: correlation between 2C19 and S-mephenytoin 4'-hydroxylation.

  1993influential reference
• Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.

  1992cited by this paper
• Substituted pyridines: nonsteroidal inhibitors of human placental aromatase cytochrome P-450.

  1992cited by this paper
• Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1.

  1991cited by this paper
• Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse.

  1990cited by this paper
• Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

  1989cited by this paper
• Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse.

  1988cited by this paper
• High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver.

  1987cited by this paper
• Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition.

  1987cited by this paper
• Quantitative determination of dextromethorphan and three metabolites in urine by reverse-phase high-performance liquid chromatography.

  1984influential reference
• Cytochrome P-450 spin state: inorganic biochemistry of haem iron ligation and functional significance.

  1984cited by this paper
• Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. Oxidation of alcohols.

  1982cited by this paper
• Substrate interaction with cytochrome P-450.

  1981cited by this paper
• A simple and sensitive assay of 7-ethoxycoumarin deethylation.

  1978cited by this paper
• Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy.

  1978cited by this paper
• Characteristics of a microsomal cytochrome P-448-mediated reaction. Ethoxyresorufin O-de-ethylation.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976influential reference
• Cytochrome P-450-linked monooxygenase system and drug-induced spectral interactions in human liver microsomes.

  1974cited by this paper

• Inhibition of CYP2A6-mediated nicotine metabolism: A potential strategy for smoking cessation therapy.

  2025cites this paper
• Ionic Liquid 1-Octyl-3-Methylimidazolium (M8OI) Is Mono-Oxygenated by CYP3A4 and CYP3A5 in Adult Human Liver

  2024cites this paper
• Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)

  2023cites this paper
• CYP2C19 Plays a Major Role in the Hepatic N-Oxidation of Cotinine

  2022cites this paper
• Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment.

  2022cites this paper
• Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in MAOB-Knockout Human Hepatoma Cells

  2022influential citation
• Metabolism of 6:2 Fluorotelomer Alcohol by CYP 2A6

  2021cites this paper
• Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity.

  2021cites this paper
• Versatile applicability of a grid-based CYP3A4 Template to understand the interacting mechanisms with the small-size ligands; part 3 of CYP3A4 Template study.

  2020cites this paper
• Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells

  2020cites this paper
• A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products

  2020cites this paper
• Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers

  2019cites this paper
• Genetically determined metabolism of nicotine and its clinical significance.

  2019cites this paper
• Allosteric activation of cytochrome P450 3A4 by efavirenz facilitates midazolam binding

  2018cites this paper
• Screening of drug metabolizing enzymes for fusidic acid and its interactions with isoform-selective substrates in vitro

  2017cites this paper
• Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng

  2016cites this paper
• Sodium tanshinone IIA sulfonate and its interactions with human CYP450s

  2016cites this paper
• [2+2+2]‐Cyclotrimerization of 1‐Cyclopropyl‐1,6‐diynes with Alkynes: Formation of Cyclopropylarenes.

  2016cites this paper
• Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro

  2016cites this paper
• Validated, Ultra High Efficiency RP-HPLC and Stability Indicating Method for Determination of Tranylcypromines Sulphate in Bulk and in Tablet Dosage Forms.

  2016cites this paper
• Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates.

  2015cites this paper
• The Interaction Between Genetics and Tobacco Consumption in Light Smokers

  2014cites this paper
• Searching the Cytochrome P450 Enzymes for the Metabolism of Meranzin Hydrate: A Prospective Antidepressant Originating from Chaihu-Shugan-San

  2014cites this paper
• A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.

  2014cites this paper
• Electrochemical detection of human cytochrome P450 2A6 inhibition: a step toward reducing dependence on smoking.

  2014cites this paper
• Rational design of novel CYP2A6 inhibitors.

  2014cites this paper
• An Overview of Phenylcyclopropylamine Derivatives: Biochemical and Biological Significance and Recent Developments

  2013cites this paper
• Comparison of p450 enzymes between cynomolgus monkeys and humans: p450 identities, protein contents, kinetic parameters, and potential for inhibitory profiles.

  2013cites this paper
• Evaluation of Inhibition Selectivity for Human Cytochrome P450 2A Enzymes

  2012cites this paper
• Nicotine Metabolism and its Implications

  2012cites this paper
• Complementary products and drug interactions: screening for the potential to cause pharmacokinetic interactions

  2012cites this paper
• Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes

  2012cites this paper
• Cytochromes P450: Inhibition of CYP2A Enzymes Involved in Xenobiotic Metabolism and Generation of CYP26 Enzymes Involved in Retinoic Acid Metabolism

  2012cites this paper
• CYP2A6: genetics, structure, regulation, and function

  2012cites this paper
• Construction of a CYP2E1-template system for prediction of the metabolism on both site and preference order

  2011cites this paper
• CYP2C19 Progress Curve Analysis and Mechanism-Based Inactivation by Three Methylenedioxyphenyl Compounds

  2011cites this paper
• Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity

  2011cites this paper
• Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.

  2011cites this paper
• Potential of hydroxyebastine and terfenadine alcohol to inhibit the human cytochrome P450 2J2 isoform

  2011cites this paper
• Metabolism and interactions of pesticides in human and animal in vitro hepatic models

  2010cites this paper
• New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.

  2009cites this paper
• Classification of Cytochrome P450 Inhibitors with Respect to Binding Free Energy and pIC50 Using Common Molecular Descriptors

  2009cites this paper
• An overview of the role of cytochrome P450 enzyme system in food-drug interactions and possible applications in veterinary medicine

  2009cites this paper
• Structure, function, regulation and polymorphism of human cytochrome P450 2A6.

  2009cites this paper
• Nicotine chemistry, metabolism, kinetics and biomarkers.

  2009cites this paper
• Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines

  2008cites this paper
• Nicotine metabolism and urinary elimination in mouse: in vitro and in vivo

  2008cites this paper
• Inhibition and induction of human cytochrome P450 enzymes: current status

  2008cites this paper
• Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme—an in silico approach

  2008cites this paper
• Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone.

  2008cites this paper
• In vitro metabolism and interactions of the fungicide metalaxyl in human liver preparations.

  2007cites this paper
• New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three‐dimensional quantitative structure‐activity relationship (3D‐QSAR) analysis

  2007cites this paper
• In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies.

  2007cites this paper
• Timolol Metabolism in Human Liver Microsomes Is Mediated Principally by CYP2D6

  2007cites this paper
• Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: A comparative study in vitro

  2007cites this paper
• Non-nicotinic therapies for smoking cessation.

  2007cites this paper
• Cytochrome P450 enzymes— in vitro , in vivo , and in silico studies

  2006cites this paper
• Tranylcypromine

  2006cites this paper
• Genetic and environmental influences on therapeutic and toxicity outcomes: studies with CYP2A6.

  2006cites this paper
• Cytochrome P450 (CYP) inhibition screening: comparison of three tests.

  2006cites this paper
• Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.

  2005cites this paper
• Metabolism and Disposition Kinetics of Nicotine

  2005influential citation
• An overview of psychotropic drug-drug interactions.

  2005cites this paper
• High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.

  2005cites this paper
• Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.

  2005cites this paper
• Mechanism-Based Inactivation of Human Cytochrome P4502C8 by Drugs in Vitro

  2004cites this paper
• Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.

  2004cites this paper
• Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.

  2003cites this paper
• Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition.

  2003cites this paper
• INVOLVEMENT OF CYP 3 A 4 , CYP 2 C 8 , AND CYP 2 D 6 IN THE METABOLISM OF ( R )-AND ( S )-METHADONE IN VITRO

  2003cites this paper
• In vitro inhibition of human small intestinal and liver microsomal astemizole O -demethylation: different contribution of CYP2J2 in the small intestine and liver

  2003cites this paper
• More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde

  2003cites this paper
• Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes.

  2003cites this paper
• Inhibition of cytochrome p450 enzymes by enrofloxacin in the sea bass (Dicentrarchus labrax).

  2003cites this paper
• Determination of 6-hydroxychlorzoxazone and chlorzoxazone in porcine microsome samples.

  2003cites this paper
• In vitro approaches in evaluation and prediction of drug-drug interactions involving the inhibition of cytochrome P450 enzymes

  2002cites this paper
• Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes.

  2002influential citation
• Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns.

  2002cites this paper
• In vitro metabolic characteristics of cytochrome P-450 2A6 in Chinese liver microsomes.

  2002cites this paper
• Human CYPs: in vivo and clinical aspects

  2002cites this paper
• Summary of information on human CYP enzymes: human P450 metabolism data

  2002cites this paper
• A High Throughput Screening Assay to Screen for CYP2E1 Metabolism and Inhibition Using a Fluorogenic Vivid® P450 Substrate

  2002cites this paper
• Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential.

  2002cites this paper
• INVOLVEMENT OF CYP 3 A IN THE METABOLISM OF EPLERENONE IN HUMANS AND DOGS : DIFFERENTIAL METABOLISM BY CYP 3 A 4 AND CYP 3 A 5

  2002cites this paper
• GEMFIBROZIL INHIBITS CYP 2 C 8-MEDIATED CERIVASTATIN METABOLISM IN HUMAN LIVER MICROSOMES

  2002cites this paper
• Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5.

  2002cites this paper